I’ve been looking into some upcoming trials for new cardiac devices and noticed several protocols focus heavily on patient selection criteria. It’s interesting how different institutions adapt certain tech specs, and wondering if anyone else has insights on the challenges faced during those initial phases of trial design. What have your experiences been like with similar trials?